DENTSPLY SIRONA (XRAY) to Release Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) will likely be issuing its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $0.30 per share and revenue of $854.75 million for the quarter.

DENTSPLY SIRONA Stock Down 3.4 %

Shares of XRAY opened at $13.37 on Wednesday. DENTSPLY SIRONA has a 52-week low of $12.16 and a 52-week high of $29.13. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a fifty day simple moving average of $14.42 and a two-hundred day simple moving average of $17.77. The company has a market capitalization of $2.66 billion, a PE ratio of -6.46, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.79%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -14.07%.

Analyst Ratings Changes

Several analysts have recently weighed in on XRAY shares. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Finally, Mizuho decreased their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Twelve research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.45.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.